Search &amp; screen the market by signal.

$371.0B

-1.9% 1D

$419.82

P/E

29.0

P/S

0.8

Net mgn

2.8%

70th pct

Rev gro

11.8%

58th pct

Dilution · Jun '25

2AZNNYSE🔥

ASTRAZENECA PLC

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

12 shown

Oct 21, 2016·9y ago·Routine

Company Update

Filings current to Jun 29 · prices to Jun 29. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Floor: $50M market cap, $1 price.

$277.2B

+1.4% 1D

$190.95

P/E

46.5

P/S

6.1

Net mgn

13.0%

86th pct

Rev gro

3.3%

43rd pct

13D · Feb '26

3CVSNYSE🔥

CVS HEALTH Corp

Consumer Staples

$130.1B

-0.7% 1D

$103.58

P/E

15.5

P/S

0.4

Net mgn

2.3%

58th pct

Rev gro

10.9%

69th pct

Red 8-K

4CINYSE🔥

Cigna Group

$78.8B

-1.4% 1D

$278.74

P/E

12.5

P/S

0.3

Net mgn

2.3%

70th pct

Rev gro

40.8%

78th pct

Dilution · Sep '25

5ALNYNASDAQ

ALNYLAM PHARMACEUTICALS, INC.

$37.8B

+0.7% 1D

$293.52

P/E

120.4

P/S

10.2

Net mgn

8.4%

80th pct

Rev gro

65.2%

84th pct

Red 8-K

6NTRANASDAQ🔥

Natera, Inc.

$30.4B

+4.0% 1D

$272.31

P/E

—

P/S

12.1

Net mgn

-9.0%

58th pct

Rev gro

35.9%

76th pct

Red 8-K

7IQVNYSE⚡

IQVIA HOLDINGS INC.

$30.3B

+1.1% 1D

$193.28

P/E

22.3

P/S

1.9

Net mgn

8.3%

80th pct

Rev gro

5.9%

48th pct

Red 8-K

8BIIBNASDAQ

BIOGEN INC.

$29.5B

+0.3% 1D

$216.63

P/E

21.5

P/S

3.0

Net mgn

13.8%

87th pct

Rev gro

0.6%

40th pct

13D · May '26

9RPRXNASDAQ⚡

Royalty Pharma plc

$24.3B

+1.5% 1D

$57.09

P/E

17.9

P/S

10.0

Net mgn

55.7%

97th pct

Rev gro

1.0%

40th pct

13D · 15d ago

10UTHRNASDAQ⚡

UNITED THERAPEUTICS Corp

$23.2B

+0.4% 1D

$544.92

P/E

18.0

P/S

7.3

Net mgn

40.6%

96th pct

Rev gro

10.6%

56th pct

Red 8-K

11DGXNYSE🔥

QUEST DIAGNOSTICS INC

$22.5B

+1.3% 1D

$212.64

P/E

20.9

P/S

2.0

Net mgn

9.5%

82nd pct

Rev gro

11.8%

58th pct

12ROIVNASDAQ

Roivant Sciences Ltd.

$21.6B

+1.9% 1D

$34.73

P/E

—

P/S

2615.8

Net mgn

-4817.3%

2nd pct

Rev gro

-71.6%

9th pct

13INSMNASDAQ

INSMED Inc

$21.2B

+1.3% 1D

$104.74

P/E

—

P/S

25.9

Net mgn

-144.4%

28th pct

Rev gro

66.7%

84th pct

Dilution · Jun '25

14MRNANASDAQ🔥

Moderna, Inc.

$19.8B

+3.6% 1D

$69.70

P/E

—

P/S

8.9

Net mgn

-143.6%

28th pct

Rev gro

-39.9%

16th pct

15NBIXNASDAQ

NEUROCRINE BIOSCIENCES INC

$16.1B

+0.9% 1D

$170.00

P/E

24.0

P/S

5.2

Net mgn

21.6%

91st pct

Rev gro

51.6%

81st pct

Red 8-K

16JAZZNASDAQ

Jazz Pharmaceuticals plc

$14.5B

+3.4% 1D

$237.72

P/E

25.9

P/S

3.6

Net mgn

13.8%

87th pct

Rev gro

6.1%

48th pct

Red 8-K

17BBIONASDAQ

BridgeBio Pharma, Inc.

$13.1B

+2.5% 1D

$72.01

P/E

—

P/S

22.6

Net mgn

-125.9%

30th pct

Rev gro

126.3%

90th pct

13D · Apr '26Red 8-K

18IONSNASDAQ

IONIS PHARMACEUTICALS INC

$12.1B

-0.6% 1D

$80.69

P/E

—

P/S

11.4

Net mgn

-30.9%

46th pct

Rev gro

33.8%

75th pct

Red 8-K

19ICLRNASDAQ⚡

ICON PLC

$11.2B

+1.8% 1D

$172.99

P/E

20.2

P/S

1.4

Net mgn

6.9%

78th pct

Rev gro

4.1%

44th pct

20RVTYNYSE🔥

REVVITY, INC.

$11.1B

-1.6% 1D

$111.21

P/E

46.1

P/S

3.9

Net mgn

8.4%

80th pct

Rev gro

3.7%

43rd pct

21RDYNYSE

DR REDDYS LABORATORIES LTD

$11.1B

-3.4% 1D

$14.86

P/E

16.5

P/S

2.9

Net mgn

17.6%

90th pct

Rev gro

13.8%

60th pct

22BMRNNASDAQ

BIOMARIN PHARMACEUTICAL INC

$10.8B

-2.3% 1D

$57.67

P/E

40.2

P/S

3.3

Net mgn

8.3%

80th pct

Rev gro

12.9%

59th pct

Red 8-K

23ARWRNASDAQ

ARROWHEAD PHARMACEUTICALS, INC.

$10.5B

+2.0% 1D

$80.50

P/E

—

P/S

16.9

Net mgn

-43.7%

42nd pct

Rev gro

23258.2%

100th pct

Dilution · Jan '26Red 8-K

24KRYSNASDAQ⚡

Krystal Biotech, Inc.

$9.4B

+1.6% 1D

$378.15

P/E

41.7

P/S

22.5

Net mgn

53.9%

97th pct

Rev gro

667.5%

96th pct

25CORTNASDAQ

CORCEPT THERAPEUTICS INC

$8.9B

+0.7% 1D

$87.89

P/E

83.9

P/S

12.0

Net mgn

14.3%

87th pct

Rev gro

39.9%

77th pct

Red 8-K

26ATRNYSE

APTARGROUP, INC.

Materials

$7.5B

-0.6% 1D

$125.29

P/E

19.4

P/S

1.9

Net mgn

10.0%

73rd pct

Rev gro

5.4%

61st pct

Dilution · Nov '25Red 8-K

27GKOSNYSE

GLAUKOS Corp

$7.4B

-1.5% 1D

$142.19

P/E

—

P/S

14.7

Net mgn

-37.0%

44th pct

Rev gro

32.3%

75th pct

28PRAXNASDAQ⚡

Praxis Precision Medicines, Inc.

$7.4B

+7.0% 1D

$350.56

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

Dilution · Jan '26

29PTGXNASDAQ

Protagonist Therapeutics, Inc

$7.1B

-0.2% 1D

$121.63

P/E

—

P/S

95.3

Net mgn

-154.9%

27th pct

Rev gro

-23.3%

21st pct

Red 8-K

30IMVTNASDAQ

Immunovant, Inc.

$6.9B

-0.9% 1D

$38.51

P/E

—

P/S

276.7

Net mgn

-1039.5%

9th pct

Rev gro

—

13D · Dec '25Dilution · Dec '25

31LQDANASDAQ

Liquidia Corp

$6.3B

-3.9% 1D

$75.12

P/E

284.0

P/S

22.0

Net mgn

7.7%

78th pct

Rev gro

1031.2%

97th pct

32PTCTNASDAQ

PTC THERAPEUTICS, INC.

$6.2B

-3.4% 1D

$81.57

P/E

—

P/S

7.5

Net mgn

-22.6%

49th pct

Rev gro

84.5%

87th pct

Red 8-K

33CNTA

Centessa Pharmaceuticals plc

$6.1B

+0.8% 1D

$40.50

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · 5d agoDilution · Nov '25Red 8-K · 7d ago

34RYTMNASDAQ⚡

RHYTHM PHARMACEUTICALS, INC.

$6.1B

+0.2% 1D

$110.04

P/E

—

P/S

27.9

Net mgn

-93.3%

33rd pct

Rev gro

45.8%

79th pct

Dilution · Jul '25Red 8-K

35MIRMNASDAQ

Mirum Pharmaceuticals, Inc.

$6.1B

-0.6% 1D

$123.00

P/E

—

P/S

10.6

Net mgn

-140.2%

29th pct

Rev gro

54.7%

81st pct

13D · Jan '26

36SRRKNASDAQ

Scholar Rock Holding Corp

$5.3B

+0.4% 1D

$54.96

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Nov '25Red 8-K · Jun '25

37CRSPNASDAQ⚡

CRISPR Therapeutics AG

$4.9B

+2.6% 1D

$56.35

P/E

—

P/S

1195.3

Net mgn

-13856.5%

0th pct

Rev gro

-90.6%

6th pct

Dilution · Oct '25Red 8-K

38TVTXNASDAQ⚡

Travere Therapeutics, Inc.

$4.8B

-0.9% 1D

$58.30

P/E

—

P/S

9.0

Net mgn

-4.0%

62nd pct

Rev gro

237.9%

93rd pct

Dilution · May '26Red 8-K

39TWSTNASDAQ

Twist Bioscience Corp

$4.7B

-1.5% 1D

$98.36

P/E

—

P/S

11.6

Net mgn

-19.8%

51st pct

Rev gro

20.3%

66th pct

40BLLNNASDAQ⚡

BillionToOne, Inc.

$4.7B

+1.9% 1D

$120.40

P/E

158.1

P/S

13.1

Net mgn

8.3%

80th pct

Rev gro

—

13D · Jan '26Dilution · Nov '25

41TNLNYSE⚡

Travel & Leisure Co.

Consumer Discretionary

$4.6B

-0.4% 1D

$77.72

P/E

20.1

P/S

1.2

Net mgn

5.7%

71st pct

Rev gro

7.2%

63rd pct

42DNTHNASDAQ⚡

Dianthus Therapeutics, Inc. /DE/

$4.5B

+0.3% 1D

$95.68

P/E

—

P/S

2203.6

Net mgn

-7973.3%

1st pct

Rev gro

-67.3%

10th pct

Dilution · Mar '26

43MANENYSE

Veradermics, Inc

$4.0B

-2.6% 1D

$123.58

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · May '26Dilution · Apr '26

44ZGNNYSE

Ermenegildo Zegna N.V.

Consumer Discretionary

$3.9B

-2.1% 1D

$12.87

P/E

25.5

P/S

1.8

Net mgn

7.1%

75th pct

Rev gro

27.6%

87th pct

45EWTXNASDAQ⚡

Edgewise Therapeutics, Inc.

$3.7B

-1.3% 1D

$40.92

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Apr '26Dilution · Apr '25

46CRNXNASDAQ

Crinetics Pharmaceuticals, Inc.

$3.6B

+0.7% 1D

$36.94

P/E

—

P/S

201.1

Net mgn

-2747.2%

4th pct

Rev gro

91.8%

87th pct

Dilution · Jan '26Red 8-K · Mar '26

47ACADNASDAQ⚡

ACADIA PHARMACEUTICALS INC

$3.6B

-0.5% 1D

$25.20

P/E

9.6

P/S

3.3

Net mgn

34.3%

95th pct

Rev gro

47.5%

79th pct

13D · Feb '26Red 8-K

48DNLINASDAQ

Denali Therapeutics Inc.

$3.4B

+1.3% 1D

$25.89

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

Dilution · Dec '25

49PHINNYSE

PHINIA INC.

Consumer Discretionary

$3.2B

-4.1% 1D

$81.33

P/E

24.3

P/S

0.9

Net mgn

3.7%

62nd pct

Rev gro

2.4%

46th pct

Red 8-K · Feb '26

50RCUSNYSE

Arcus Biosciences, Inc.

$3.0B

+0.3% 1D

$31.08

P/E

—

P/S

12.7

Net mgn

-156.4%

27th pct

Rev gro

-4.3%

31st pct

Dilution · Oct '25

51TARSNASDAQ

Tarsus Pharmaceuticals, Inc.

$2.7B

-2.6% 1D

$61.26

P/E

—

P/S

5.9

Net mgn

-14.7%

54th pct

Rev gro

146.7%

91st pct

Dilution · Mar '25

52RARENASDAQ

Ultragenyx Pharmaceutical Inc.

$2.4B

-0.3% 1D

$30.68

P/E

—

P/S

3.6

Net mgn

-90.9%

34th pct

Rev gro

55.0%

81st pct

Red 8-K

53BCRXNASDAQ

BIOCRYST PHARMACEUTICALS INC

$2.2B

-3.9% 1D

$9.55

P/E

—

P/S

2.5

Net mgn

-51.7%

40th pct

Rev gro

94.1%

88th pct

Red 8-K

54KODNASDAQ

Kodiak Sciences Inc.

$2.1B

+5.0% 1D

$37.74

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Dec '25Dilution · Dec '25

55IMNMNASDAQ

Immunome Inc.

$2.1B

+5.4% 1D

$21.04

P/E

—

P/S

518.4

Net mgn

-5593.8%

1st pct

Rev gro

-23.2%

21st pct

13D · Dec '25Dilution · Dec '25

56HRMYNASDAQ

Harmony Biosciences Holdings, Inc.

$2.0B

-0.4% 1D

$35.34

P/E

13.7

P/S

2.2

Net mgn

16.2%

88th pct

Rev gro

21.5%

67th pct

Red 8-K

57ADMANASDAQ

ADMA BIOLOGICS, INC.

$1.9B

-4.3% 1D

$8.37

P/E

11.5

P/S

3.7

Net mgn

32.4%

95th pct

Rev gro

19.6%

65th pct

58JBLUNASDAQ🔥

JETBLUE AIRWAYS CORP

Industrials

$1.9B

-6.2% 1D

$5.63

P/E

—

P/S

0.2

Net mgn

-7.8%

20th pct

Rev gro

-5.8%

26th pct

13D · 22d ago

59ANIPNASDAQ

ANI PHARMACEUTICALS INC

$1.9B

-0.5% 1D

$84.11

P/E

20.2

P/S

2.0

Net mgn

10.0%

83rd pct

Rev gro

43.8%

78th pct

Red 8-K · Apr '26

60VRDNNASDAQ

Viridian Therapeutics, Inc.DE

$1.8B

+5.0% 1D

$18.79

P/E

—

P/S

25.5

Net mgn

-483.6%

16th pct

Rev gro

22463.4%

99th pct

13D · May '26Dilution · May '26

61NRIXNASDAQ🔥

Nurix Therapeutics, Inc.

$1.8B

+4.2% 1D

$23.85

P/E

—

P/S

24.4

Net mgn

-411.4%

17th pct

Rev gro

—

Dilution · Mar '26

62AGIONASDAQ

AGIOS PHARMACEUTICALS, INC.

$1.8B

+0.4% 1D

$38.04

P/E

—

P/S

26.5

Net mgn

-639.8%

13th pct

Rev gro

48.0%

80th pct

Red 8-K

63QURENASDAQ🔥

uniQure N.V.

$1.7B

-0.3% 1D

$47.39

P/E

—

P/S

96.1

Net mgn

-1154.4%

8th pct

Rev gro

1.6%

41st pct

Dilution · 7d agoRed 8-K

64BHVNNYSE⚡

Biohaven Ltd.

$1.7B

-5.6% 1D

$14.95

P/E

—

P/S

2.0

Net mgn

-108.3%

32nd pct

Rev gro

—

Dilution · May '26

65NTLANASDAQ⚡

Intellia Therapeutics, Inc.

$1.7B

-0.4% 1D

$16.61

P/E

—

P/S

25.6

Net mgn

-597.0%

14th pct

Rev gro

86.5%

87th pct

Dilution · Apr '26

66RXRXNASDAQ

RECURSION PHARMACEUTICALS, INC.

$1.7B

+4.8% 1D

$3.69

P/E

—

P/S

22.4

Net mgn

-863.4%

10th pct

Rev gro

26.9%

71st pct

13D · Dec '25Dilution · Feb '26Red 8-K

67AAPGNASDAQ

ASCENTAGE PHARMA GROUP INTERNATIONAL

$1.6B

+5.5% 1D

$17.70

P/E

—

P/S

12.2

Net mgn

-41.4%

42nd pct

Rev gro

—

Dilution · Jan '25

68TSHANASDAQ

Taysha Gene Therapies, Inc.

$1.6B

+6.2% 1D

$6.73

P/E

—

P/S

219.6

Net mgn

-1738.4%

6th pct

Rev gro

17.3%

63rd pct

Dilution · 6d ago

69AMLXNASDAQ

Amylyx Pharmaceuticals, Inc.

$1.6B

+5.1% 1D

$18.70

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

Dilution · Sep '25

70SRPTNASDAQ

Sarepta Therapeutics, Inc.

$1.6B

+1.0% 1D

$17.02

P/E

—

P/S

0.7

Net mgn

-32.5%

46th pct

Rev gro

15.6%

61st pct

Red 8-K

71PGENNASDAQ

PRECIGEN, INC.

$1.6B

+1.0% 1D

$5.92

P/E

—

P/S

50.2

Net mgn

-647.0%

13th pct

Rev gro

—

13D · Mar '26Red 8-K

72PVLANASDAQ

PALVELLA THERAPEUTICS, INC.

$1.6B

+4.5% 1D

$154.84

P/E

—

P/S

602.6

Net mgn

-1610.6%

7th pct

Rev gro

—

Dilution · Feb '26Red 8-K

73FTRENASDAQ

Fortrea Holdings Inc.

$1.6B

-0.7% 1D

$17.52

P/E

—

P/S

0.6

Net mgn

-16.5%

53rd pct

Rev gro

-12.4%

24th pct

Red 8-K

74SLSNASDAQ

SELLAS Life Sciences Group, Inc.

$1.5B

+24.7% 1D

$15.45

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Oct '25Red 8-K · Jun '25

75PRGONYSE🔥

PERRIGO Co plc

$1.5B

+1.0% 1D

$10.05

P/E

—

P/S

0.4

Net mgn

-43.5%

42nd pct

Rev gro

-2.8%

33rd pct

Red 8-K

76CAPRNASDAQ

CAPRICOR THERAPEUTICS, INC.

$1.5B

-10.0% 1D

$23.80

P/E

—

P/S

67.1

Net mgn

-181.7%

25th pct

Rev gro

-11.5%

25th pct

Dilution · Dec '25

77IMCRNASDAQ

Immunocore Holdings plc

$1.5B

-1.5% 1D

$30.42

P/E

—

P/S

3.6

Net mgn

-6.7%

60th pct

Rev gro

29.0%

72nd pct

78URGNNASDAQ

UroGen Pharma Ltd.

$1.4B

+4.4% 1D

$36.07

P/E

—

P/S

10.3

Net mgn

-94.8%

33rd pct

Rev gro

21.4%

67th pct

Red 8-K

79HROWNASDAQ

HARROW, INC.

$1.4B

-2.2% 1D

$41.15

P/E

—

P/S

5.2

Net mgn

-1.9%

64th pct

Rev gro

36.4%

76th pct

Red 8-K · Sep '25

80IARTNASDAQ

INTEGRA LIFESCIENCES HOLDINGS CORP

$1.4B

-0.1% 1D

$18.74

P/E

—

P/S

0.8

Net mgn

-30.1%

46th pct

Rev gro

1.5%

41st pct

Red 8-K

81INBXNASDAQ

Inhibrx Biosciences, Inc.

$1.4B

+0.7% 1D

$95.50

P/E

—

P/S

1040.5

Net mgn

-10014.2%

0th pct

Rev gro

550.0%

95th pct

82AVLNNASDAQ

Avalyn Pharma Inc.

$1.3B

+0.9% 1D

$31.00

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · May '26Dilution · Apr '26

83XERSNASDAQ

Xeris Biopharma Holdings, Inc.

$1.2B

+0.7% 1D

$7.74

P/E

97.6

P/S

3.7

Net mgn

3.8%

73rd pct

Rev gro

—

Red 8-K

84WVENASDAQ

Wave Life Sciences Ltd.

$1.1B

-2.6% 1D

$5.68

P/E

—

P/S

15.7

Net mgn

-255.7%

22nd pct

Rev gro

-60.5%

11th pct

13D · Apr '26Dilution · Dec '25

85MGRTNASDAQ

Mega Fortune Co Ltd

Technology

$1.0B

-2.4% 1D

$75.24

P/E

1896.6

P/S

313.4

Net mgn

16.5%

83rd pct

Rev gro

—

13D · 41d agoDilution · Jul '25

86XNCRNASDAQ

Xencor Inc

$914M

+3.6% 1D

$15.60

P/E

—

P/S

9.4

Net mgn

-177.1%

26th pct

Rev gro

-25.4%

20th pct

Red 8-K · Mar '25

87PHARNASDAQ

Pharming Group N.V.

$904M

+0.5% 1D

$13.40

P/E

—

P/S

3.7

Net mgn

-4.3%

62nd pct

Rev gro

19.3%

65th pct

88MGTXNASDAQ

MeiraGTx Holdings plc

$888M

+3.5% 1D

$12.54

P/E

—

P/S

11.1

Net mgn

-151.1%

28th pct

Rev gro

144.6%

91st pct

13D · Apr '26Dilution · Apr '26

89AMPHNASDAQ

Amphastar Pharmaceuticals, Inc.

$886M

-4.9% 1D

$20.71

P/E

11.2

P/S

1.2

Net mgn

11.0%

84th pct

Rev gro

11.7%

57th pct

90ETONNASDAQ

Eton Pharmaceuticals, Inc.

$865M

+2.9% 1D

$36.73

P/E

—

P/S

10.8

Net mgn

-5.8%

61st pct

Rev gro

104.9%

89th pct

Red 8-K · Jun '25

91LXRXNASDAQ

LEXICON PHARMACEUTICALS, INC.

$853M

+3.5% 1D

$2.64

P/E

—

P/S

12.2

Net mgn

-37.5%

44th pct

Rev gro

60.2%

83rd pct

13D · May '26Dilution · Feb '26Red 8-K · Jan '25

92CERTNASDAQ

Certara, Inc.

Technology

$809M

+8.9% 1D

$6.36

P/E

—

P/S

1.9

Net mgn

-3.6%

45th pct

Rev gro

8.7%

50th pct

Red 8-K

93ZVRANASDAQ

ZEVRA THERAPEUTICS, INC.

$748M

+3.6% 1D

$14.01

P/E

9.0

P/S

7.0

Net mgn

78.2%

98th pct

Rev gro

350.9%

94th pct

94REPLNASDAQ

Replimune Group, Inc.

$733M

-3.7% 1D

$11.20

P/E

—

P/S

—

Net mgn

—

Rev gro

—

95RLMDNASDAQ

RELMADA THERAPEUTICS, INC.

$698M

+4.3% 1D

$6.98

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Jan '26Red 8-K · Jul '25

96CLYMNASDAQ

Climb Bio, Inc.

$655M

+2.1% 1D

$13.36

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Apr '26Dilution · 19d agoRed 8-K

97IMMXNASDAQ

Immix Biopharma, Inc.

$602M

+5.1% 1D

$10.49

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · 41d ago

98IRWDNASDAQ

IRONWOOD PHARMACEUTICALS INC

$601M

+4.1% 1D

$4.30

P/E

5.9

P/S

1.7

Net mgn

28.3%

94th pct

Rev gro

-15.7%

23rd pct

13D · Mar '26Red 8-K · Jul '25

99DRUGNASDAQ

BRIGHT MINDS BIOSCIENCES INC.

$598M

+5.2% 1D

$69.18

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Jan '26

100GYRENASDAQ

GYRE THERAPEUTICS, INC.

$575M

+2.5% 1D

$6.45

P/E

—

P/S

4.9

Net mgn

-1.2%

65th pct

Rev gro

10.2%

55th pct

13D · May '26Dilution · May '25Red 8-K

Acquisition / Disposition · Results of Operations

Jul 2, 2025·1y ago·Strategic

May 14, 2018·8y ago·Red Alert

8-K/A

Executive Change · Shareholder Vote

Apr 2, 2018·8y ago·Red Alert

Executive Change · Reg FD Disclosure

May 11, 2018·8y ago·Red Alert

Executive Change · Shareholder Vote

LSTALISATA THERAPEUTICS, INC.

May 8, 2014·12y ago·Strategic

Acquisition / Disposition · Results of Operations

AMGNAMGEN INC

May 19, 2026·1mo ago·Red Alert

Executive Change

Jul 25, 2019·7y ago·Routine

Company Update

May 12, 2025·1y ago·Strategic

Material Agreement · Company Update

Aug 16, 2018·7y ago·Routine

Reg FD Disclosure

VNRXVOLITIONRX LTD

Mar 29, 2021·5y ago·Red Alert

Executive Change

TXMDTherapeuticsMD, Inc.